Devatis Limited is a licensed pharmaceutical company in New Zealand. Being active since 2007 in New Zealand, the company was initially incorporated as DEVA Holdings NZ Ltd and amended its name as Devatis Limited as of March 20, 2017. Devatis Limited is 100% owned by DEVA Holding A.S. which is one of the leading pharmaceutical companies in Turkey. Through DEVA Holding A.S., Devatis Ltd. is a part of globally active EastPharma group companies. Having an enterprising and innovative attitude in the pharmaceutical market, DEVA Holding A.S. is active in several important territories all over the world. The essential aim is to make perfect quality medicines available for everyone. In this respect, DEVA is working devotedly at its EU-GMP and US FDA approved, state-of-art manufacturing facilities with approximately 2500 employees.
Established in 1958, DEVA Holding has approximately 600 products in in the Turkish pharmaceuticals market and with excellent manufacturing capabilities for nearly all kind of pharmaceutical forms, DEVA develops, produces, markets and sells its high-quality finished products, APIs and veterinary products worldwide. DEVA offers a wide range of products in various therapeutical areas including antibacterial, antineoplastic, musculoskeletal, cardiovascular, gastrointestinal, respiratory, central nervous system, dermatology and hormones.
DEVA Holding has approximately 600 products in 13 therapeutic areas including Hematology & oncology, ophthalmology and respiratory system products amongst others creating difference by launching new products into market every single year.
DEVA production facilities have been approved and certified by EU GMP and US FDA with an annual output capacity of 578 million units. Manufacturing capacity allows production of different pharmaceutical forms at large scales:
• Injectable Products (Ampoules, Vials)
• Eye Drops
• Sterile Pomads
• Gels & Ointments
• Syrups and Solutions
• Metered-Dose Inhalers (MDI) and Dry-Powder Inhalers (DPI)
The high quality of DEVA production facilities are endorsed by globally recognized certification bodies:
DEVA has three manufacturing facilities which are endorsed by internationally recognized certifications proving the high quality standards of DEVA.
• Semi-Solid Dosage Forms:
Creams, Gels, Ointments, Suppository
• Solid Dosage Forms:
• Liquid Dosage Forms:
Solutions, Suspensions, Syrups, Solutions and Suspensions for Nebulisers
• Metered-Dose Inhalers (MDI), Dry-Powder Inhalers (DPI)
• Separate Production Building for:
Cephalosporines (Tablets, Dry Syrups, Vials)
Penicillins (Tablets, Dry Syrups, Vials)
• Hormones (Tablets, Creams, Gels, Ointments, Vials, Drops)
• Separate Production Plant for Onctology Products (Tablets, Capsules)
• Separate Production Plant for Steril Oncology Products (Vials)
• Active Ingredient Synthesis (API)
Location: Turkey’s Largest Logistics Center
In 2018, Turkey’s largest pharmaceutical logistics center, started its operations with 32000 pallet capacity and received EU GMP approval
• Sterile liquids in ampoules and vials
• Lyophilized products in vials
• Small volume parenterals with blow fill seal technology
Unit doses (LDPE)
Multi doses (LDPE)
•Empty medical ampoule